-
E.
Kavalali,
L.
Monteggia
(2018)
The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects
Neuropsychopharmacology, 43
-
L.
Aleksandrova,
Y.
Wang,
A.
Phillips
(2020)
Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression
Molecular Brain, 13
-
(
KangHParkPBortolottoZA, et al (2017) Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology
112(Pt A): 144–149.27520396)
KangHParkPBortolottoZA, et al (2017) Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology
112(Pt A): 144–149.27520396
KangHParkPBortolottoZA, et al (2017) Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology
112(Pt A): 144–149.27520396,
KangHParkPBortolottoZA, et al (2017) Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties. Neuropharmacology
112(Pt A): 144–149.27520396
-
(
IngramRKangHLightmanS, et al (2018) Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology
142: 30–40.29885421)
IngramRKangHLightmanS, et al (2018) Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology
142: 30–40.29885421
IngramRKangHLightmanS, et al (2018) Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology
142: 30–40.29885421,
IngramRKangHLightmanS, et al (2018) Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology
142: 30–40.29885421
-
R.
Ingram,
Heather
Kang,
S.
Lightman,
D.
Jane,
Z.
Bortolotto,
G.
Collingridge,
D.
Lodge,
A.
Volianskis
(2018)
Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity
Neuropharmacology, 142
-
(
LumsdenEWTroppoliTAMyersSJ, et al (2019) Antidepressant-relevant concentrations of the ketamine metabolite (2 R,6 R)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America
116(11): 5160–5169.30796190)
LumsdenEWTroppoliTAMyersSJ, et al (2019) Antidepressant-relevant concentrations of the ketamine metabolite (2 R,6 R)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America
116(11): 5160–5169.30796190
LumsdenEWTroppoliTAMyersSJ, et al (2019) Antidepressant-relevant concentrations of the ketamine metabolite (2 R,6 R)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America
116(11): 5160–5169.30796190,
LumsdenEWTroppoliTAMyersSJ, et al (2019) Antidepressant-relevant concentrations of the ketamine metabolite (2 R,6 R)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America
116(11): 5160–5169.30796190
-
P.
Zanos,
R.
Moaddel,
Patrick
Morris,
Polymnia
Georgiou,
J.
Fischell,
G.
Elmer,
M.
Alkondon,
P.
Yuan,
Heather
Pribut,
Nagendra
Singh,
K.
Dossou,
Yuhong
Fang,
Xi-Ping
Huang,
Cheryl
Mayo,
I.
Wainer,
E.
Albuquerque,
S.
Thompson,
Craig
Thomas,
C.
Zarate,
T.
Gould
(2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Nature, 533
-
(
YangYCuiYSangK, et al (2018) Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature
554(7692): 317–322.29446381)
YangYCuiYSangK, et al (2018) Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature
554(7692): 317–322.29446381
YangYCuiYSangK, et al (2018) Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature
554(7692): 317–322.29446381,
YangYCuiYSangK, et al (2018) Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature
554(7692): 317–322.29446381
-
(
AleksandrovaLRWangYTPhillipsAG (2020) Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression. Molecular Brain
13(1): 92.32546197)
AleksandrovaLRWangYTPhillipsAG (2020) Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression. Molecular Brain
13(1): 92.32546197
AleksandrovaLRWangYTPhillipsAG (2020) Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression. Molecular Brain
13(1): 92.32546197,
AleksandrovaLRWangYTPhillipsAG (2020) Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression. Molecular Brain
13(1): 92.32546197
-
N.
Anis,
S.
Berry,
N.
Burton,
D.
Lodge
(1983)
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate
British Journal of Pharmacology, 79
-
R.
Berman,
A.
Cappiello,
A.
Anand,
D.
Oren,
G.
Heninger,
D.
Charney,
J.
Krystal
(2000)
Antidepressant effects of ketamine in depressed patients
Biological Psychiatry, 47
-
J.
Stringer,
P.
Guyenet
(1983)
Elimination of long-term potentiation in the hippocampus by phencyclidine and ketamine
Brain Research, 258
-
P.
Zanos,
R.
Moaddel,
Patrick
Morris,
L.
Riggs,
Jaclyn
Highland,
Polymnia
Georgiou,
E.
Pereira,
E.
Albuquerque,
Craig
Thomas,
C.
Zarate,
T.
Gould
(2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Pharmacological Reviews, 70
-
G.
Collingridge,
S.
Kehl,
H.
Mclennan
(1983)
Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus.
The Journal of Physiology, 334
-
(
AnisNABerrySCBurtonNR, et al (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. British Journal of Pharmacology
79(2): 565–575.6317114)
AnisNABerrySCBurtonNR, et al (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. British Journal of Pharmacology
79(2): 565–575.6317114
AnisNABerrySCBurtonNR, et al (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. British Journal of Pharmacology
79(2): 565–575.6317114,
AnisNABerrySCBurtonNR, et al (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. British Journal of Pharmacology
79(2): 565–575.6317114
-
Antidepressant actions of ketamine versus hydroxynorketamine
-
(
AutryAEAdachiMNosyrevaE, et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature
475(7354): 91–95.21677641)
AutryAEAdachiMNosyrevaE, et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature
475(7354): 91–95.21677641
AutryAEAdachiMNosyrevaE, et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature
475(7354): 91–95.21677641,
AutryAEAdachiMNosyrevaE, et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature
475(7354): 91–95.21677641
-
S.
Kotermanski,
Jon
Johnson
(2009)
Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
The Journal of Neuroscience, 29
-
T.
Bliss,
G.
Collingridge
(1993)
A synaptic model of memory: long-term potentiation in the hippocampus
Nature, 361
-
(
BlissTVCollingridgeGL (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature
361(6407): 31–39.8421494)
BlissTVCollingridgeGL (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature
361(6407): 31–39.8421494
BlissTVCollingridgeGL (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature
361(6407): 31–39.8421494,
BlissTVCollingridgeGL (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature
361(6407): 31–39.8421494
-
(
CollingridgeGLKehlSJMcLennanH (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. The Journal of Physiology
334(1): 33–46.6306230)
CollingridgeGLKehlSJMcLennanH (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. The Journal of Physiology
334(1): 33–46.6306230
CollingridgeGLKehlSJMcLennanH (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. The Journal of Physiology
334(1): 33–46.6306230,
CollingridgeGLKehlSJMcLennanH (1983) Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. The Journal of Physiology
334(1): 33–46.6306230
-
(
StringerJLGuyenetPG (1983) Elimination of long-term potentiation in the hippocampus by phencyclidine and ketamine. Brain Research
258(1): 159–164.24010182)
StringerJLGuyenetPG (1983) Elimination of long-term potentiation in the hippocampus by phencyclidine and ketamine. Brain Research
258(1): 159–164.24010182
StringerJLGuyenetPG (1983) Elimination of long-term potentiation in the hippocampus by phencyclidine and ketamine. Brain Research
258(1): 159–164.24010182,
StringerJLGuyenetPG (1983) Elimination of long-term potentiation in the hippocampus by phencyclidine and ketamine. Brain Research
258(1): 159–164.24010182
-
Dr.
Collingridge,
Yeseul
Lee,
Z.
Bortolotto,
Heather
Kang,
D.
Lodge,
L.
Prof.Graham,
Ernest
Collingridge,
Leonard
Chair
(2016)
Antidepressant Actions of Ketamine vs. Hydroxynorketamine. Biological Psychiatry, e65-e67.
-
(
BermanRMCappielloAAnandA, et al (2000) Antidepressant effects of ketamine in depressed patients. Biological Psychiatry
47(4): 351–354.10686270)
BermanRMCappielloAAnandA, et al (2000) Antidepressant effects of ketamine in depressed patients. Biological Psychiatry
47(4): 351–354.10686270
BermanRMCappielloAAnandA, et al (2000) Antidepressant effects of ketamine in depressed patients. Biological Psychiatry
47(4): 351–354.10686270,
BermanRMCappielloAAnandA, et al (2000) Antidepressant effects of ketamine in depressed patients. Biological Psychiatry
47(4): 351–354.10686270
-
Yan
Yang,
Yihui
Cui,
Kangning
Sang,
Yiyan
Dong,
Zheyi
Ni,
Shuangshuang
Ma,
Hailan
Hu
(2018)
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Nature, 554
-
(
CollingridgeGLLeeYBortolottoZA, et al (2017) Antidepressant actions of ketamine versus hydroxynorketamine. Biological Psychiatry
81(8): e65–e67.27817845)
CollingridgeGLLeeYBortolottoZA, et al (2017) Antidepressant actions of ketamine versus hydroxynorketamine. Biological Psychiatry
81(8): e65–e67.27817845
CollingridgeGLLeeYBortolottoZA, et al (2017) Antidepressant actions of ketamine versus hydroxynorketamine. Biological Psychiatry
81(8): e65–e67.27817845,
CollingridgeGLLeeYBortolottoZA, et al (2017) Antidepressant actions of ketamine versus hydroxynorketamine. Biological Psychiatry
81(8): e65–e67.27817845
-
Anita
Autry,
M.
Adachi,
E.
Nosyreva,
E.
Na,
Maarten
Los,
Peng
Cheng,
E.
Kavalali,
L.
Monteggia
(2011)
NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses
Nature, 475
-
(
KavalaliETMonteggiaLM (2018) The ketamine metabolite 2R,6R-hydroxynorketamine blocks NMDA receptors and impacts downstream signaling linked to antidepressant effects. Neuropsychopharmacology
43(1): 221–222.29192654)
KavalaliETMonteggiaLM (2018) The ketamine metabolite 2R,6R-hydroxynorketamine blocks NMDA receptors and impacts downstream signaling linked to antidepressant effects. Neuropsychopharmacology
43(1): 221–222.29192654
KavalaliETMonteggiaLM (2018) The ketamine metabolite 2R,6R-hydroxynorketamine blocks NMDA receptors and impacts downstream signaling linked to antidepressant effects. Neuropsychopharmacology
43(1): 221–222.29192654,
KavalaliETMonteggiaLM (2018) The ketamine metabolite 2R,6R-hydroxynorketamine blocks NMDA receptors and impacts downstream signaling linked to antidepressant effects. Neuropsychopharmacology
43(1): 221–222.29192654
-
(
ZanosPMoaddelRMorrisPJ, et al (2018) Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacological Reviews
70(3): 621–660.29945898)
ZanosPMoaddelRMorrisPJ, et al (2018) Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacological Reviews
70(3): 621–660.29945898
ZanosPMoaddelRMorrisPJ, et al (2018) Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacological Reviews
70(3): 621–660.29945898,
ZanosPMoaddelRMorrisPJ, et al (2018) Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacological Reviews
70(3): 621–660.29945898
-
(
ZanosPMoaddelRMorrisPJ, et al (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature
533(7604): 481–486.27144355)
ZanosPMoaddelRMorrisPJ, et al (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature
533(7604): 481–486.27144355
ZanosPMoaddelRMorrisPJ, et al (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature
533(7604): 481–486.27144355,
ZanosPMoaddelRMorrisPJ, et al (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature
533(7604): 481–486.27144355
-
E.
Lumsden,
Timothy
Troppoli,
S.
Myers,
P.
Zanos,
Y.
Aracava,
J.
Kehr,
Jacqueline
Lovett,
Sukhan
Kim,
Fu‐Hua
Wang,
S.
Schmidt,
Carleigh
Jenne,
P.
Yuan,
Patrick
Morris,
Craig
Thomas,
C.
Zarate,
R.
Moaddel,
S.
Traynelis,
E.
Pereira,
S.
Thompson,
E.
Albuquerque,
T.
Gould
(2019)
Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
Proceedings of the National Academy of Sciences, 116
-
R)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America
-
Heather
Kang,
Pojeong
Park,
Z.
Bortolotto,
S.
Brandt,
Tristan
Colestock,
J.
Wallach,
G.
Collingridge,
D.
Lodge
(2017)
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
Neuropharmacology, 112
-
(
KotermanskiSEJohnsonJW (2009) Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer’s drug memantine. Journal of Neuroscience
29(9): 2774–2779.19261873)
KotermanskiSEJohnsonJW (2009) Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer’s drug memantine. Journal of Neuroscience
29(9): 2774–2779.19261873
KotermanskiSEJohnsonJW (2009) Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer’s drug memantine. Journal of Neuroscience
29(9): 2774–2779.19261873,
KotermanskiSEJohnsonJW (2009) Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer’s drug memantine. Journal of Neuroscience
29(9): 2774–2779.19261873